Adverse Event Reporting
| VAERS ID | 919022 |
|---|---|
| Gender | Male |
| Age | 28 |
| StateCode | MD |
| Pharmaceutical Company | MODERNA |
| Lot Number | |
| Number of vaccinations | 2 |
| Vaccinated | 2020-09-02 |
| Onset | 2020-09-02 |
| Condition | Permanent Disability |
Symptoms
- Pyrexia
- Tachycardia
- Electrocardiogram
- Electrocardiogram ambulatory
- Magnetic resonance imaging brain
- Echocardiogram
- Ophthalmological examination
- Blindness unilateral
- Autoantibody positive
- Computerised tomogram coronary artery
- Postural orthostatic tachycardia syndrome
Current Illness
Preexisting Conditions
Other Medications
Dutastride 0.5 mg/day, Wellbutrin XL 300 mg/day, Truvada (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg)/day.
Previous Vaccinations
Allergies
doxycycline-gastrointestinal.
Laboratory Data
Eye exam, MRI of brain and orbits, Holter monitor, EKG, Echocardiogram, CT cardiac calcium score.
Write-up
Complete loss of vision in the left eye 12 hours after receiving second dose (Moderna mRNA-1273) while having a fever of 102 F for 6 hours.
Loss of vision lasted for 1 minute.
Loss of vision occurred while standing.
Referral to primary care and ophthalmology specialist found normal eye exam and MRI of orbits but presence of tachycardia especially while standing (fluctuations between 60 beats at rest/laying down to 130 beats per minute standing).
Postural tachycardia syndrome (POTS) is suspected.
Currently pursuing cardiac workup with cardiologist and Covid POTS specialist.
POTS specialist believes autoantibody development after vaccination could be suspected as recovering covid patients similarly present to clinic with POTS like symptoms.